BTC $63,055.64 -0.02%
ETH $1,881.68 -0.05%
BNB $606.76 -0.16%
XRP $1.00 -0.36%
SOL $75.51 -0.10%
TRX $0.3309 -0.55%
DOGE $0.0697 -0.76%
ADA $0.1765 -2.62%
BCH $203.55 -1.26%
LINK $9.48 -2.45%
HYPE $57.15 +0.98%
AAVE $86.30 -0.39%
SUI $0.6755 -1.34%
XLM $0.1569 -1.45%
ZEC $485.94 -1.62%
BTC $63,055.64 -0.02%
ETH $1,881.68 -0.05%
BNB $606.76 -0.16%
XRP $1.00 -0.36%
SOL $75.51 -0.10%
TRX $0.3309 -0.55%
DOGE $0.0697 -0.76%
ADA $0.1765 -2.62%
BCH $203.55 -1.26%
LINK $9.48 -2.45%
HYPE $57.15 +0.98%
AAVE $86.30 -0.39%
SUI $0.6755 -1.34%
XLM $0.1569 -1.45%
ZEC $485.94 -1.62%

The listed company Galmed plans to allocate 50% of its cash reserves to cryptocurrency

2025-08-25 20:00:41

ChainCatcher news, according to PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. announced the implementation of a digital asset management strategy, with plans to allocate $10 million (approximately 50% of current cash reserves) for digital asset investments.

The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. This strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies.

To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.

app_icon
ChainCatcher Building the Web3 world with innovations.